olaparib,bevacizumab
Merck,roche,AstraZeneca
['gyn', 'ovarian', 'olaparib']
two studies report long-term survival benefits with olaparib in (women with) ovarian cancer #ovca #gyncsm #parpi 
A/Prof UNSW. Border Medical Oncology Albury Wodonga Regional Cancer Centre @AWRCCentre PCPA President https://t.co/soCid5JOE5 SIOG, ASCO, COSA, MOGA, MASCC, IGCS